GDR vs. AGL, YGEN, ABDX, PRM, VRCI, GENI, IDHC, LLAI, DMTR, and LLA
Should you be buying genedrive stock or one of its competitors? The main competitors of genedrive include ANGLE (AGL), Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), Verici Dx (VRCI), GENinCode (GENI), Integrated Diagnostics (IDHC), LungLife AI (LLAI), Deepmatter Group (DMTR), and LLA.L,0P0001T9GN,0 (LLA). These companies are all part of the "diagnostics & research" industry.
genedrive vs.
ANGLE (LON:AGL) and genedrive (LON:GDR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation, dividends and community ranking.
genedrive has lower revenue, but higher earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.
ANGLE has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500. Comparatively, genedrive has a beta of -0.04, meaning that its stock price is 104% less volatile than the S&P 500.
ANGLE's return on equity of -63.75% beat genedrive's return on equity.
ANGLE currently has a consensus target price of GBX 70, indicating a potential upside of 460.00%. Given ANGLE's stronger consensus rating and higher probable upside, equities research analysts plainly believe ANGLE is more favorable than genedrive.
genedrive received 60 more outperform votes than ANGLE when rated by MarketBeat users. Likewise, 72.67% of users gave genedrive an outperform vote while only 62.33% of users gave ANGLE an outperform vote.
In the previous week, ANGLE's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.
18.8% of ANGLE shares are owned by institutional investors. Comparatively, 0.3% of genedrive shares are owned by institutional investors. 16.2% of ANGLE shares are owned by insiders. Comparatively, 14.8% of genedrive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
ANGLE beats genedrive on 9 of the 15 factors compared between the two stocks.
Get genedrive News Delivered to You Automatically
Sign up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
genedrive Competitors List
Related Companies and Tools
This page (LON:GDR) was last updated on 1/22/2025 by MarketBeat.com Staff
Free GDR Stock Alerts